Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial
暂无分享，去创建一个
E. Pérez-Nadales | R. León-López | J. Torre-Cisneros | F. Martínez-Marcos | N. Merchante | J. C. Garrido-Gracia | B. Gutiérrez-Gutiérrez | E. León | S. Cárcel | C. Fernández-Roldán | I. Pérez-Camacho | Pedro María Martínez Pérez-Crespo | C. Riazzo | C. de la Fuente | D. Vinuesa | A. Romero-Palacios | A. Jurado | A. Navas | Reinaldo Espíndola-Gómez | E. Alonso | Alexandra Aceituno Caño | Marta Trigo-Rodríguez | María Ángeles Esteban Moreno | Juan E Corzo-Delgado